Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged Cash Flow
TSE:ABT's free cash flow for Q3 2020 was $13.76M. For the 2020 fiscal year, TSE:ABT's free cash flow was decreased by $13.92M and operating cash flow was $14.71M. See a summary of the company’s cash flow.
Cash Flow
Jun 20
Jun 19
Jun 18
Operating Cash Flow
$ 24.96M
$ 10.26M
$ 12.55M
Investing Cash Flow
$ -3.82M
$ -19.78M
$ -2.91M
Financing Cash Flow
$ -9.73M
$ -5.68M
$ -8.16M
End Cash Position
$ 29.73M
$ 18.69M
$ 33.96M
Free Cash Flow
$ 21.10M
$ 7.18M
$ 9.64M
Currency in USD
Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged Cash Flow